Espinosa-Cárdenas DA, Bautista-de Anda R

Language: Spanish
References: 16
Page: 193-198
PDF size: 565.58 Kb.

ABSTRACT

Introduction: over the last few years, the infarction code has been implemented in IMSS. However, there is no quick way of knowing how complicated a patient might be. Other studies have been conducted, but there is currently no study evaluating the usefulness of this index in a Mexican population.
Objective: for the following article, a prospective study was conducted in HGZ N° 58 to analyse and identify this index as a prognostic marker of in-hospital evolution in patients with ST-elevation AMI.
Methodology: the study was conducted in the population of Tlalnepantla corresponding to HGZ N° 58, in the period between September 2023 and February 2024. The study was authorised as a research protocol before the SIRECIS with registration number R2023-1503- 059 and approved with sheet F-2023-1503-055. The study was conducted with a sample of 75 patients using the exclusion method, resulting in a 2x2 matrix.
Discussion: the mean leukoglycaemic index was greater than 1, and this difference was statistically significant, as having a leukoglycaemic index greater than 1 increases the likelihood of morbidity during acute myocardial infarction.
Conclusion: in the statistical analysis, we can observe a leukoglycaemic index of 0.99234, which gives us a sensitivity of approximately 76% and false positives of 52%. Our cut-off points on the curve are (0.758; 0.524). Specificity indicates that the test is able to correctly identify 55.6% of patients with a good prognosis. The ROC curve is not significant in this sample size.

REFERENCES

1. Rodríguez Jiménez, A., Fardales Rodríguez, R., Toledo Rodríguez,E., & Quintana Cañizarez, G. (2019). Índice leuco-glucémico comofactor pronóstico tras un infarto agudo del miocardio con elevacióndel segmento ST. Finlay, 9(2), 97–107. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342019000200097

2. Arroyo Álvarez, G. (2018). Utilidad del índice Leucoglucémicocomo predictor de muerte en pacientes con infarto agudo de Miocardio.

3. Jiménez, A. R., Rodríguez, R. F., Rodríguez, E. T., & Cañizarez, G.Q. (2019). Índice leuco-glucémico como factor pronóstico tras uninfarto agudo del miocardio con elevación del segmento ST. Finlay,9(2), 97–107. http://www.revfinlay.sld.cu/index.php/finlay/article/view/636

4. Rodríguez Serrano J. Pronóstico de mortalidad en pacientes coninfarto agudo del miocardio sin elevación del segmento ST enrelación al índice leuco/glucémico en el servicio urgencias de laUMAE 14. 2020 https://cdigital.uv.mx/handle/1944/50398

5. Reyes-Villarreal, J. C., Morales-Gutiérrez, J. E., López-Zamora, B.,Reyes-Navarro, G. V., Ordoñez-González, I., & Triana-González, S.(s/f). Índice leucoglucémico en pacientes con infarto miocárdico conelevación del ST. Rev Med Inst Mex Seguro Soc, 60(2).

6. 6 León-Aliz, E., Moreno-Martínez, F. L., Pérez-Fernández, G. A.,Vega-Fleites, L. F., & Rabassa-López-Calleja, M. A. (2014). Índiceleuco-glucémico como marcador pronóstico de la evoluciónintrahospitalaria en pacientes con infarto agudo de miocardio conelevación del ST. Clinica e investigacion en arteriosclerosis: publicacionoficial de la Sociedad Espanola de Arteriosclerosis, 26(4),168–175. https://doi.org/10.1016/j.arteri.2014.01.002

7. Rodríguez Jiménez, Ailed, Fardales Rodríguez, Raikel, Toledo Rodríguez,Enrique, & Quintana Cañizarez, Guillermo. (2019). Índiceleuco-glucémico como factor pronóstico tras un infarto agudo delmiocardio con elevación del segmento ST. Revista Finlay, 9(2),97-107. Epub 02 de agosto de 2019. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342019000200097&lng=es&tlng=es.

8. Cuesta-Mero, P. L., García-Romo, L. A., & Villacres-López, Á. D.(2022). Índice leucoglucémico como marcador pronóstico de complicacionesen pacientes con infarto agudo de miocardio. Revistacolombiana de cardiologia, 28(2). https://doi.org/10.24875/rccar.m21000023

9. Hirschson, A., Higa, C., Merlo, P., Domine, E., Blanco, P., & Vásquez,G. (2014). Prognostic Value of the Leuko-glycemic Index inAcute Myocardial Infarction. Results from the SCAR MulticenterRegistry. Rev Argent Cardiol, 82, 475–480.

10. ESC Guidelines for the management of acute myocardial infarctionin patients presenting with ST-segment elevation. The TaskForce on the management of ST-segment elevation acute myocardialinfarction of the European Society of Cardiology (ESC).(2012). European Heart Journal, 33, 2569–2619.

11. Miyamoto, Y. (2014). Could glucose management after acute myocardialinfarction cure myocardial damage? Circulation Journal:Official Journal of the Japanese Circulation Society, 78(1), 67–68.https://doi.org/10.1253/circj.cj-13-1460

12. Pesaro, A., Nicolau, J., Serrano, C., Marcus, R., Gaz, V., Roberto,R., Roberto, G., & Ramires, J. (2009). Influencia de Leucocitosy Glucemia en el Pronóstico de Pacientes con Infarto Agudo deMiocardio Arq Bras Cardiol. 92, 84–89.

13. Menon, V., Lessard, D., Yarzebski, J., Furman, M. I., Gore, J.M., & Goldberg, R. J. (2003). Leukocytosis and adverse hospitaloutcomes after acute myocardial infarction. The American Journalof Cardiology, 92(4), 368–372. https://doi.org/10.1016/s0002-9149(03)00651-9

14. Reyes, M., Echeverría, F., Ch, C., Lange, J., Escalante, J., Comisario,R., Onocko, M., Prieto, R., Zoni, G., & Burgos, R. (2013). Teoríainflamatoria del sca: índice leucoglucémico como factor pronóstico.Instituto de Cardiología de Corrientes Año 10 - No. 30.

15. León-Aliz, E., Moreno-Martínez, F. L., Pérez-Fernández, G. A.,Vega-Fleites, L. F., & Rabassa-López-Calleja, M. A. (2014). Índiceleuco-glucémico como marcador pronóstico de la evoluciónintrahospitalaria en pacientes con infarto agudo de miocardio conelevación del ST. Clinica e investigacion en arteriosclerosis: publicacionoficial de la Sociedad Espanola de Arteriosclerosis, 26(4),

16. 168–175. https://doi.org/10.1016/j.arteri.2014.01.002